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Abstract
Background Musculoskeletal pain is associated with comor-
bidity, extensive use of health services, long-term disability
and reduced quality of life. The scientific literature on effects
of treatment for musculoskeletal pain is inconclusive.
Purpose The purpose of this study is to compare a mul-
tidisciplinary intervention (MI), including use of the novel
Interdisciplinary Structured Interview with a Visual
Educational Tool (ISIVET), with a brief intervention (BI),
on effects onmental and physical symptoms, functioning abil-
ity, use of health services and coping in patients sick-listed due
to musculoskeletal pain.
Method Two hundred eighty-four adults aged 18–60, referred
to a specialist clinic in physical rehabilitation, were random-
ized to MI or BI. Patients received a medical examination at
baseline and completed a comprehensive questionnaire at
baseline, 3 months and 12 months.
Results Both groups reported improvements in mental and
physical symptoms, including pain, and improved functioning
ability at 3 and 12 months, but the MI group improved faster
than the BI group except from reports of pain, which had a
similar course. Significant interactions between group and
time were found on mental symptoms (anxiety (p<0.05), de-
pression (p<0.01), somatization (p<0.01)) and functioning
ability (p<0.01) due to stronger effects in the MI group at
3 months. At 3 and 12 months, the MI group reported signif-
icantly less use of health services (general practitioner
(p<0.05)). At 12 months, the MI group reported better self-
evaluated capability of coping with complaints (p<0.001) and
they took better care of their own health (p<0.001), compared
to the BI group.
Conclusion The results indicate that the MI may represent an
important supplement in the treatment of musculoskeletal
pain.
Keywords Randomized clinical trial . Chronic
musculoskeletal pain .Multidisciplinary treatment .
Patient education tool
Introduction
Musculoskeletal pain conditions such as fibromyalgia and low
back pain are, in the majority of cases, unspecific and com-
posite [1]. Although non-malignant, they represent substantial
suffering and economic loss for the individual itself and for
the society due to frequent contacts with the health care sys-
tem, absence from work and reduced quality of life [2–6]. In
Norway, musculoskeletal diagnoses represent about 45 % of
the long-term sick leave [7]. Most of the patients have other
subjective health complaints as well, where pathological find-
ings are absent or substantially less than expected, compared
to the reported intensity of the complaints [8]. There is general
consensus in the literature that these conditions are multicaus-
al [9] and comorbid [8, 10, 11]. Psychological and social fac-
tors, as well as somatic pathology, influence chronicity and
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disability [12]. This indicates that the optimal treatment
should focus on several aspects of the patient’s life [1, 12,
13]. Improved incorporation of patient preferences into
treatment recommendations can improve adherence to
treatment and thereby improve the clinical outcomes
[14]. Multidisciplinary treatment is a well-accepted and
well-documented method to treat chronic pain [13, 15,
16], and education combined with physical exercise pro-
duces some positive effects in long-term follow-up for
fibromyalgia and musculoskeletal pain [13]. The
European guidelines for low back pain state that the
optimal content of multidisciplinary programs requires fur-
ther research, but behavioural treatment and stress manage-
ment are important components of these programs [1]. There
is, however, a lack of systematic content or description of
such, in many of these programs.
The aim of this study was to compare the effects of a mul-
tidisciplinary intervention (MI) and a brief intervention (BI),
on mental and physical health complaints, functioning ability
and coping in patients on long-term sick leave due to muscu-
loskeletal complaints. The study is part of a randomized clin-
ical trial (trial reg. nr. NCT01346423) where return to work
was the main outcome.
Material and Methods
Five hundred thirty-four patients with musculoskeletal pain
referred to a specialist outpatient clinic, at the Department of
Physical Medicine and Rehabilitation, Innlandet Hospital
Trust, Norway, between 2011 and 2013, were considered for
participation in the trial. Patients were referred from general
practitioners (GPs) in 48 municipalities in two different
counties in the south-eastern part of Norway. The inclusion
criteria were as follows: age between 20 and 60 years, at least
50 % sick leave due to musculoskeletal pain for less than
12 months and at least 50 % employed. The exclusion criteria
were as follows: pregnancy, current cancer, osteoporosis, re-
cent physical trauma/injury, serious mental illness, rheumatic
inflammatory diseases, not capable of understanding and
speaking Norwegian or being involved in an on-going health
insurance claim. Of the 534 patients, 250 were either not eli-
gible or excluded for different reasons. Two hundred eighty-
four (mean age 41.3 years, 54 % females) patients were in-
cluded in the study and randomized to either MI (n=141) or
BI (n=143) (Fig. 1). The patients included were referred from
136 different GPs who referred between one and eight patients
each.
Interventions
The two interventions were given by different teams and at
two different outpatient clinics.
The MI with the ISIVET
Baseline Treatment SessionA social worker, a physician and
a physiotherapist performed the MI. Initially, they consulted
the patient successively. Each consultation was two-parted:
First, an interview and, eventually, a physical examination
and, secondly, the use of ISIVET.
In the first part, the social worker interviewed the patient on
her/his social situation (family life, social life, education, eco-
nomics) and work situation, while the physician did a com-
prehensive interview covering past and present physical
and mental health for the patient and his/her family. The
physician also elaborated on coping and fear avoidance
in relation to the pain problems, in addition to a phys-
ical examination, concluding with a diagnosis according
to ICD-10. The physiotherapist assessed the musculo-
skeletal problems of the patient through interview and a
physical examination.
During the second part of each consultation, the therapists
used the ISIVET. The method is developed by the first author
(RB) and consists of two figures, a manual, a table for filling
out a rehabilitation plan and a list where possible rehabilitation
initiatives are categorized. Each figure is a star plot with seven
axes representing different variables (Fig. 2). Each axis has the
range from 1 (centrally) to 10 (peripherally). The patient
scored her/himself with assistance from the therapist and guid-
ing from the manual, on each variable on this numeric scale,
where B1^ indicates a maximum negative situation whereas
B10^ indicates an optimally positive situation. The manual
gives illustrating examples of the situation at different
levels. Patient and therapist read the manual together,
and through discussion, they identified the right score
for each variable and marked it on the actual axis in a
paper version of the figure. When all scores were complet-
ed, a line was drawn between the seven scores giving an area
in each of the two figures. The area under the lines was
coloured for better visualization for the patient as well as for
the therapists. Problem areas or challenges were demonstrated
as lack of colour, while existing resources stood out as
coloured area.
The first figure Bworking conditions^ included the
following variables: work-related stress, satisfaction with
job tasks, workload, collegial relationships, leadership,
degree of challenges at work and occupational partici-
pation. It was filled out during the consultation with the
social worker. The second figure Bquality of life^ in-
cluded the following variables: physical complaints,
psychological well-being, sleep, energy, physical activi-
ty, social participation and occupational participation
and was filled out during the consultation with the phy-
sician and the physiotherapist.
When the sessions with the three therapists were
completed, the whole team met briefly, sharing their
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findings and general impression of the patient and her/
his situation at work and at home. Possible barriers to
work participation, maintaining factors to the on-going
pain problems and, eventually, other important issues
were highlighted. The patient then joined the meeting
to a final discussion with the team on her/his situation,
health problems and work situation. The two figures
from the ISIVET were central when discussing possible
fields of actions. The patient decided ways to go for-
ward, and agreement on actions was written down in a
table and categorized according to the standardized pro-
tocol. These action items comprised the patient’s reha-
bilitation plan and were typically related to cognitive
assessment of health, as fear avoidance and catastrophic
thinking, lifestyle and, if relevant, family and work mat-
ters. Actions could also involve physical exercise or
increased daily physical activity. When leaving the clin-
ic, the patient received a paper copy of the figures with
the coloured areas and the rehabilitation plan listed as
points to be followed. A copy of the complete medical
3 months treatment session 
Treatment drop-out (n = 7)
3 months Q-follow-up
Return Q: n=112 (79.4%)
2 weeks treatment session 
Treatment drop-out: n=15
Baseline treatment session 
BI   (n=143)
Treatment drop-out: n=0
Return Q: n=141 (98.6%)
Baseline treatment session 
MI (n=141)
Treatment drop-out: n=0
Return Q: n=139 (98.6%)
2 weeks treatment session 
Treatment drop-out: n=4
Assessed for eligibility (screened)  
n= 534
Patients randomized (n= 284) to:
Multidisciplinary Intervention (MI) n=141
Brief Intervention (BI) n=143
250 patients were not eligible:           
- 100 did not want to   participate
- 43 unable to contact (by phone)
107 not meeting criteria:
- 40 not sick-listed
- 29 < 50% sick-listed
- 13 < 50% employed
- 11 sick listed > 1 year
- 5 on-going treatment another 
specialist
- 2 age > 60 years
- 2 pregnant
- 2 on-going insurance claim
- 1 did not speak Norwegian
- 1 osteoporosis
- 1 on-going cancer
3 months Q-follow-up
Return Q: n=95 (66.4%)
12 months Q-follow-up
Return Q: n=85 (60.3%)
ISIVET by phone: n=97 
(68.8%)
12 months Q-follow-up
Return Q: n=87 (60.8%)
Fig. 1 Flowchart of
participation, in treatment
sessions and questionnaires (Q)
follow-up
Fig. 2 Example of figure Bquality of life^ filled in three times
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record was sent both to the GP and the patient. The baseline
assessment lasted about 3.5 h.
After 2 weeks, the patient and the physiotherapist met for
about 1 h to evaluate the rehabilitation plan and work
through the ISIVET once more. New scores and new
areas were marked in the figures made at baseline, and
areas were coloured with a new colour (Fig. 2).
Visualization of delta areas in the star plot was matter of
attention and reflection. Previous advice and actions were
highlighted according to this, and adjustments in the re-
habilitation plan were eventually made.
After 3 months, the patient met with the whole team for
about 1 h to sum up the situation and evaluate the inter-
ventions so far. The ISIVET was worked through, and
new areas on the figures were coloured with a third col-
our. Eventually, they adjusted the rehabilitation plan.
At 12months follow-up, the physiotherapist contacted the
patient by phone to score the two figures in the ISIVET a
last time. This was a brief contact that lasted about
15 min.
To ensure adherence to the protocol and equal practice of
the method, the MI team had regular meetings for supervision
and discussions. Four physicians, all specializing in physical
medicine and rehabilitation, two social workers and four
physiotherapists did the treatment. The team members
were the same during the treatment course of one patient.
Audiotaping was not used.
The BI
BI is a standardized intervention based on the studies by
Indahl [17] and Molde Hagen [18], and details on the method
are described in the pioneer work of Indahl [10, 17].
BI comprised of two sessions. The baseline session lasted
about 2.5 h and included separate consultations with the phy-
sician and the physiotherapist. After 2 weeks, the patients had
a follow-up session with the physiotherapist for about 1 h.
The basic principle of the BI is the non-injury model, em-
phasizing the lack of any objective signs of injury [17, 19] and
the non-directive communication [20, 21]. BI has proven
more effective on return to work (RTW), health complaints
and functional ability, than usual care both for chronic low
back pain and non-specific muscular pain conditions [18,
20]. The goal is to reduce fear and concern through a thorough
medical examination with explanations of each step and edu-
cation about a physiological model on musculoskeletal pain.
Any somatic findings are explained. The patient is informed
about the good prognosis and the importance of staying
active.
A physician who was specialist in physical medicine and
rehabilitation and a physiotherapist did the BI. Both were
experienced in the method. Therapist treatment manuals were
written for the intervention, based on current guidelines [1]
and on the manuals used by Indahl andMolde Hagen [10, 18].
Audiotaping was not used. The physician had been
videotaped giving BI in another trial [22]. A copy of the med-
ical record was sent both to the GP and the patient.
Randomization and Blinding
The randomization was concealed, and patients were random-
ized to either MI or BI, according to a computer-generated
randomization list set-up by a statistician at Uni Research
Health (URH). URH received information on ID number,
gender and age, and a research assistant, not involved in the
treatment, contacted URH and was informed on which treat-
ment that the patient should receive. For practical reasons,
there was no blinding to treatment of therapists or participants.
Dropout from Randomized Treatment
Patients who dropped out of treatment were asked if they were
willing to continue filling out questionnaires and return them
by mail.
Questionnaires
The patients received the questionnaires by mail and filled
them out at baseline and at 3 and 12 months follow-up. The
following questionnaires were applied:
The Hospital Anxiety and Depression Scale (HADS) cov-
ered symptoms of anxiety and depression [23]. HADS
consists of 14 items, of which seven measures anxiety
and seven depressive symptoms. Scores are made on a
four-point Likert scale ranging from 0 (Bnot at all^) to 3
(Bvery often^) on symptoms experienced during the last
week, providing 21 as a maximum sum score for each
subscale. A cut-off score of eight and above is used as an
indication of possible, anxiety or depressive disorder.
The Hopkins SymptomChecklist-25 (HSCL-25) measures
psychological distress [24]. The instrument consists of 25
questions recording the presence and intensity of the most
common symptoms of anxiety, depression and somatiza-
tion. Severity is scored on a four-point Likert scale from 1
(not at all) to 4 (Bvery much/to a severe degree^), and a
mean score <1.75 is within normal range, while a score
≥1.75 indicates psychological distress in the need of
treatment.
The Norwegian Function Assessment Scale (Norfunk)
measures four aspects of physical function and three as-
pects of psychological function during the last week by
41 questions [25]. Physical function is related to the pa-
tient’s ability to walk/stand, hold/pick, lift/carry and sit.
4 Int.J. Behav. Med. (2016) 23:1–11
Psychological function covers the ability to be attentive,
communicate, work in team, handle responsibility, han-
dle challenges of daily life, deal with criticism, cope with
anger, communicate with others and to look/listen. The
answers are scored on a four-point Likert scale from 0
(Bno problems^) to 3 (Bnot able to do the activity^).
Subjective Health Complaints (SHC) inventory is a reli-
able instrument measuring somatic and psychological
complaints experienced during the last month [26]. It
contains 29 items covering the most frequent subjective
health complaints from different parts of the body.
Severity is scored on a four-point Likert scale from 0
(not at all) to 3 (Bseriously^). The instrument has five
subscales: musculoskeletal complaints, gastrointestinal
problems, pseudoneurological problems, flu and allergy
symptoms in addition to a total score (SHC total).
Pain was measured with a Numeric Rating Scale (NRS).
The patients were asked about mean pain in the back, the
neck, the foot and during activity, at rest and at night for
the last 14 days. The severity of pain was scored from 0
(Bno pain^) to 10 (Bworst possible pain^).
At 3 and 12 months, the patients were asked if they had
been treated by GP, chiropractor or physiotherapist or had
received other treatment during the last 3 months and, if so,
for how many sessions.
At 12 months, the patients were also asked about changes,
compared to 1 year ago, in complaints, general health, coping
with health complaints, ability to take care of their own health
and physical fitness. They were also asked about satisfaction
with the treatment. Answers were scored on a five-point Likert
scale from 1 (Bmuch better^) to 5 (Bmuchworse^) except from
patient satisfaction with treatment which was assessed on a
seven-point Likert scale from 1 (Bvery satisfied^) to 7 (Bvery
dissatisfied^).
Statistics
A mixed between–within-subjects analyses of variance with
one between-group factor (MI vs. BI) and one within-subjects/
repeated measures factor (baseline, 3 months, 12 months)
were conducted to assess the effect of the two interventions
on participant scores on depression, anxiety, somatization
(HADS and HSCL), functional ability (Norfunk) and health
complaints (SHC). The interaction effects (time × group) were
calculated, and when significant, such interaction effects indi-
cate different time courses for the two interventions.
Interaction effects were followed up by t tests for paired sam-
ples within each group. Cohen’s d was calculated between
baseline and 3 months follow-up and baseline and 12 months
follow-up using an online calculator (http://easycalculation.
com/statistics/effect-size.php) based on this formula: d=M1−
M2/(√(SD12+SD22)/2). Differences for outcomes between
the two interventions in scores on pain measured by NRS
were analyzed by Mann–Whitney U test for independent
samples at 3 and 12 months. Differences for outcomes in use
of health services, patient-evaluated health changes, coping
and satisfaction with treatment at 12 months were assessed
with x2 statistics or Fisher’s exact test. Sample size calcula-
tions were in accordance with RTW expectations, which are
part of this RCT but described in another paper, and based on
data from Hagen et al. [18]. The calculation was based on a
power of 80 % and a significant level of 5 % giving an N for
this study of 300.
Ethical Considerations
The study followed the Helsinki declaration and was approved
by the Norwegian Regional Ethics Committee in south-
eastern Norway [27] and by the Norwegian Social Science
Data Services [28]. Participants gave their informed consent
by signing the declaration of voluntarily participation before
entering in the study.
Results
Demographic and Baseline Data
The study population comprised 284 individuals (mean age
41.3 years, 53.9 % women). Two hundred seventeen (76.4 %)
of the patients were married or cohabitant, 195 patients
(68.7 %) reported education limited to primary school
(≤12 years), 56 patients (19.7 %) had no children, and 238
patients (83.8 %) reported 80 % employment or more. Mean
duration of sick leave during the 8-month period before entry to
the studywas 143 days (SD=56.6) in theMI group and 150 days
(SD=62.9) in the BI group. The dominant diagnoses in accor-
dance to ICPC-2 [29] were as follows: low back pain L02/L03/
L84/L86 (39.5 %), neck pain L01/L83 (12.1 %), widespread
pain/fibromyalgia L18 (10.7 %) and shoulder pain L08/L92
(7.8 %). The whole study population constituted 51 different
diagnoses, the L group representing 84.2 %. There were no
differences in pain diagnoses between the groups at baseline.
Lost to Follow-Up
The dropout of treatment was low in both groups (Fig. 1).
Return of questionnaires dropped to 60.3 % in the MI group
and 60.8 % in the BI group at 12 months (Fig. 1).
There were no significant differences in baseline scores
between returners and non-returners of questionnaires,
except from the score on HSCL depression where the
non-returners scored significantly lower (mean=1.47, SD=
0.46) compared to the returners (mean=1.60, SD=0.55), giv-
ing a p value <0.05 of the difference.
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Changes in Anxiety, Depression and Somatization
Anxiety and depression measured with HADS and so-
matization and depression measured with HSCL showed
a significant interaction between group and time, indi-
cating that the BI group and the MI group differed
significantly on these subscales (Table 1). By 3 months,
the MI group reported improvements on anxiety, depres-
sion and somatization (all p values <0.01) measured
with HADS and HSCL, while the BI group reported a
significant worsening on HADS anxiety (p<0.01) and a
smaller improvement on anxiety, depression and somatiza-
tion measured with HSCL (all p values<0.05) compared to
the MI group. However, at 12 months, the groups were simi-
lar, with both groups reporting significantly improvements on
all subscales.
Changes in Functional Ability
Functional ability measured with Norfunk showed a signifi-
cant interaction between group and time, indicating that the BI
group and the MI group had a significantly different time
course on the functional ability (Table 2). The MI group
had significant improvements from baseline to 3 months
on six of seven subscales and on the total score (all
p values <0.01), while the BI group had significant,
but weaker improvements on two subscales (p<0.05).
By 3 months, the Cohen’s d was larger on all items of
the Norfunk in the MI group compared to the BI group, which
had negative value on three subscales, indicating deteriora-
tion. By 12 months, both groups had significant improve-
ments from baseline, but with no significant differences be-
tween the groups.
Table 1 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on anxiety, depression and soma-
tization measured by the Hospital
Anxiety and Depression Scale
(HADS) and Hopkins Symptom
Checklist (HSCL)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
HADS anxiety
Baselined 5.59 (3.29) 5.51 (3.70)
3 monthse 4.82 (3.34)** 0.27 5.74 (4.12)** −0.02
12 monthsf 4.53 (4.25)** 0.24 4.79 (4.08)** 0.28 3.79 0.02
HADS depression
Baselined 4.58 (3.42) 4.50 (3.55)
3 monthse 3.83 (3.35)** 0.32 4.86 (4.11) −0.06
12 monthsf 3.71 (3.85)** 0.21 3.99 (3.65)* 0.23 10.89 <0.00
HSCL somatization
Baselined 2.01 (0.54) 1.95 (0.58)
3 monthse 1.74 (0.49)** 0.63 1.87 (0.70)* 0.15
12 monthsf 1.69 (0.57)** 0.61 1.73 (0.67)** 0.40 8.01 <0.00
HSCL anxiety
Baselined 1.47 (0.41) 1.45 (0.40)
3 monthse 1.35 (0.34)** 0.38 1.42 (0.43)* 0.17
12 monthsf 1.32 (0.39)** 0.40 1.33 (0.44)** 0.39 2.17 0.12
HSCL depression
Baselined 1.54 (0.48) 1.55 (0.56)
3 monthse 1.35 (0.38)** 0.50 1.50 (0.58)* 0.19
12 monthsf 1.39 (0.49)** 0.36 1.40 (0.59)** 0.38 4.14 0.02
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
6 Int.J. Behav. Med. (2016) 23:1–11
Changes in SHC
There were no significant interactions between group and time
for any of the SHC subscales (Table 3). This indicates that the
two interventions did not affect SHC differently. The Cohen’s d
was larger on all items by 3months in theMI group compared to
the BI group, and the changes from baseline to 3 months were,
overall, larger in the MI group by 3 months. By 12 months, the
Table 2 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on different aspects of functional
ability (Norfunk)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
Norfunk all items
Baselined 1.44 (0.28) 1.44 (0.30)
3 monthse 1.33 (0.29)** 0.43 1.40 (0.33) 0.10
12 monthsf 1.32 (0.34)** 0.38 1.30 (0.29)** 0.51 5.52 0.01
Coping, handle responsibility, attention, concentration, work, tolerate stress
Baselined 1.44 (0.41) 1.42 (0.44)
3 monthse 1.31 (0.38)** 0.36 1.48 (0.55) −0.10
12 monthsf 1.36 (0.44)* 0.24 1.31 (0.38)* 0.27 5.80 0.01
Ability to hold, to pick, to write, to drive, to cook, to dress/undress
Baselined 1.37 (0.33) 1.36 (0.33)
3 monthse 1.27 (0.34)** 0.33 1.32 (0.36) 0.08
12 monthsf 1.25 (0.35)* 0.34 1.21 (0.30)** 0.48 3.44 0.04
Ability to stand, to walk flat, to walk stairs, to shop
Baselined 1.55 (0.52) 1.58 (0.50)
3 monthse 1.45 (0.47)** 0.29 1.47 (0.45) 0.19
12 monthsf 1.38 (0.48)** 0.35 1.39 (0.48)** 0.43 1.17 0.31
Ability to lift, to carry, to laundry, to housekeep
Baselined 1.73 (0.51) 1.71 (0.50)
3 monthse 1.53 (0.51)** 0.34 1.58 (0.50)* 0.24
12 monthsf 1.46 (0.47)** 0.50 1.46 (0.42)** 0.63 0.99 0.37
Ability to sit, to be a passenger in car/bus/train
Baselined 1.41 (0.55) 1.42 (0.55)
3 monthse 1.22 (0.41)** 0.39 1.28 (0.47)* 0.21
12 monthsf 1.22 (0.41)** 0.36 1.21.(0.37)** 0.45 1.28 0.28
Ability to communicate verbally, written and by phone, to cooperate, to perceive messengers
Baselined 1.26 (0.35) 1.26 (0.35)
3 monthse 1.24 (0.34) 0.08 1.32 (0.41) −0.12
12 monthsf 1.29 (0.40) −0.06 1.28 (0.37) 0.00 0.76 0.47
Ability to watch TV, listen to radio
Baselined 1.07 (0.19) 1.08 (0.24)
3 monthse 1.06 (0.20) 0.07 1.12 (0.29) −0.12
12 monthsf 1.09 (0.27) −0.18 1.07 (0.24) 0.02 3.77 0.03
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
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effect sizes were similar for the groups, due to improvements in
the BI group from 3 to 12months, leaving the two groups similar.
Changes in Pain
Pain by activity (MI group=6.62 (1.93), BI group=6.26
(2.11)) and back pain (MI group=5.97 (2.28), BI group=
5.69 (2.44)) was the main pain problem in both groups at
baseline. Both groups had reduction in their average pain
levels during the follow-up, but there were no significant dif-
ferences between the groups at 3 or 12 months on pain by
activity or back pain (results not shown).
Use of Health Services by 3 and 12 Months
By 3 and 12 months, the MI group had consulted their GP
significantly less than the MI group (p<0.05): By 3 months
19.4 % in the MI group and 31.8 % in the BI group had
received treatment by their GP during the last 3 months, with
about equal mean number of treatment sessions: MI=3.0 and
BI=2.8. By 12 months, the corresponding numbers were 11.8
and 18.5 %, mean MI=2.5 and BI=2.3 (p<0.05). There were
no significant differences between the groups in consulting
other therapists at 3 or 12 months follow-up.
Changes in Health Complaints/Symptoms, Coping
and Satisfaction with Treatment
By 12months, there were no significant differences between the
groups in self-evaluated changes in complaints (x2 (1, n=171)=
3.4); 85 individuals (96.5%) in theMI group and 86 (98.8%) in
the BI group reported that they still had musculoskeletal com-
plaints. By 12months, theMI group reported significantly better
ability to cope with problems (x2 (1, n=168)=22.5, p<0.001),
Table 3 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on subjective health complaints
(SHC)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
SHC total
Baselined 20.13 (9.38) 18.42 (9.39)
3 monthse 16.12 (8.97)** 0.48 17.34 (10.51)* 0.16
12 monthsf 15.71(10.22)** 0.42 15.25(10.44)** 0.42 2.20 0.11
SHC musculoskeletal complaints
Baselined 10.62 (4.24) 10.07 (4.36)
3 monthse 8.78 (4.37)** 0.47 8.83 (4.62)** 0.30
12 monthsf 8.22 (4.73)** 0.50 7.89 (4.79)** 0.57 1.64 0.20
SHC pseudoneurological symptoms
Baselined 4.96 (3.20) 4.79 (3.59)
3 monthse 3.79 (3.11)** 0.43 4.56 (3.69) 0.11
12 monthsf 3.61 (3.57)** 0.39 3.95 (3.55)** 0.33 1.40 0.25
SHC gastrointestinal symptoms
Baselined 2.67 (2.91) 1.97 (2.53)
3 monthse 2.13 (2.40)* 0.24 2.16 (2.71) 0.02
12 monthsf 2.29 (2.72) 0.15 1.94 (3.27) 0.11 0.29 0.75
SHC allergy symptoms
Baselined 1.13 (1.81) 0.91 (1.43)
3 monthse 0.82 (1.35)* 0.20 0.89 (1.35) −0.03
12 monthsf 0.74 (1.16)* 0.23 0.62 (1.08)* 0.21 2.21 0.11
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
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better ability to take care of their own health (x2 (1, n=165)=
17.3, p<0.001) and better physical fitness (x2 (1, n=165)=
15.1, p<0.01) compared to the BI group. The MI group also
reported significantly higher satisfaction with the treat-
ment (x2 (1, n=170)=41.8, p<0.001).
Discussion
Comparing the effects of a multidisciplinary intervention
(MI), including use of the novel Interdisciplinary Structured
Interview with a Visual Educational Tool (ISIVET), with a
brief intervention (BI) on patients sick-listed due to musculo-
skeletal pain, revealed no significant differences between
groups on mental and physical symptoms and functional abil-
ity at 12 months follow-up. However, patients in the MI group
had significantly better effect on anxiety, depression, somati-
zation and functional ability at 3 months follow-up, compared
to the BI group, and at 12 months follow-up, the MI group
reported better ability to cope with their problems, higher abil-
ity to take care of their own health and better physical fitness
in spite of the same level of pain, and they consulted their GP
less than patients in the BI group both at 3 and 12 months.
In Norway, treatment of musculoskeletal pain is primarily
done by the patients’GP. Chronic and more complex cases are
eventually referred to specialist health care [13, 30, 31]. It is
reasonable to assume that our study population consists of
chronic and more complex cases, as they had been sick-
listed for, on average, 147 days and were referred by their
GPs to specialist health care. The GPs had no prior knowledge
that their patients might be enrolled into a clinical study.
Typically, episodes of acute musculoskeletal pain including
LBP recover quickly, but patients who do not recover tend to
have more complex disorders where social factors, work con-
ditions, psychological and somatic factors play together in per-
petuating the condition [5, 32–34]. Clinical psychosocial fac-
tors predict long-term incapacity of musculoskeletal disorders
[35], and multidisciplinary treatments including a psychosocial
approach have been proven effective for complex illnesses [15,
36] and are well accepted in treatment of chronic pain [13, 15,
16]. The MI patients received more extensive, multidisciplin-
ary treatment, compared to the BI patients. This may explain
why theMI was more effective than the BI at 3 months follow-
up, on anxiety, depression, somatization and functional ability.
The baseline mean scores on anxiety and depression were low
for both groups. A tendency to somatization among these pa-
tients where they express stress in somatic symptoms rather
than psychologically might indicate that changes in even low
scores could be of clinical importance.
Improved communication between patient and health profes-
sionals can influence health outcomes and coping in a positive
way [37–39]. ISIVET is constructed to improve communica-
tion, patient involvement, mutual understanding and enhancing
of the therapeutic alliance. Filling in the ISIVET figures with the
therapist may represent a communication where the patient ex-
periences that her/his opinion and experiences are respected and
made relevant, leading to a mutual insight and understanding of
the situation between patient and therapist. In BI, the communi-
cation was a more traditional doctor–patient relationship where
the patient was given information and advices about physical
activity and exercises to improve their muscle pain.
Earlier trials have shown that patients who are engaged in
decision making are more motivated for changes in lifestyle
and their clinical outcomes are better [38, 40]. In shared deci-
sion making (SDM), the patient’s autonomy is strengthened
and the relationship with the therapist and the patient is im-
proved [41]. The application of ISIVET in assessment of
health complaints can facilitate patient empowerment and
SDM. This may lead to improvements of patient satisfaction,
adherence to treatment and better health outcomes [42].
Educational tools can influence the patient’s expectations
and outcomes in a beneficial way compared to traditional
health information [43]. When combining education and
physical exercise, there are some positive long-term effects
for fibromyalgia and musculoskeletal pain [13]. Application
of ISIVETwhere a visualization of the patient’s situation was
established as coloured areas in the ISIVET figures may facil-
itate the patient’s insight and understanding of the complexity
of the situation. This might improve the adherence to the re-
habilitation plan. At 12 months, the MI group reported better
ability to handle health problems and better physical fitness
and they had less use of health care services in spite of fairly
the same levels of pain and health complaints as the BI group.
Limitations and Strengths of the Study
The dropout of treatment was low, but the return of question-
naires at 12 months follow-up (∼60 %, both groups) might
affect the generalizability of the study. However, analyses
showed that non-returners of questionnaires at 12 months
had significantly lower scores onHSCL depression at baseline
compared to returners. Multiple analyses were performed,
possibly increasing the risk of finding low p values by coin-
cidence. The patients in the MI group received more therapist
time, which may have influenced the results. For practical
reasons, there was no blinding of patients or therapists for
the different treatments. The treatment sessions were unfortu-
nately not videotaped, but therapists in the BI group had been
videotaped previously [22]. Manuals were written for both
treatments to ensure equal practice of the methods. The BI
group had fewer and more experienced therapists compared
to the MI group; however, the therapists in the MI group had
regular meetings and supervision. The first author developed
the ISIVET and treated 29 patients. However, the outcomes
were based on the questionnaires that patients filled in at home
before the consultations, not on scores in the ISIVET.
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Conclusions
The results indicate that the new MI may represent an impor-
tant supplement in the multidisciplinary therapeutic work in
patients with chronic musculoskeletal pain and that visualiza-
tion, shared decision and multidisciplinary assessment can
reinforce the effect of treatment. The MI with the ISIVET
should be applied in new studies to see if results could be
reproduced or improved further.
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